SBC Medical Group (SBC) Competitors

Progyny (NASDAQ:PGNY) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

Does the media refer more to PGNY or SBC?

In the previous week, Progyny had 6 more articles in the media than SBC Medical Group. MarketBeat recorded 11 mentions for Progyny and 5 mentions for SBC Medical Group. Progyny's average media sentiment score of 0.96 beat SBC Medical Group's score of 0.62 indicating that Progyny is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Progyny	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, PGNY or SBC?

Progyny has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Do insiders & institutionals believe in PGNY or SBC?

94.9% of Progyny shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 9.4% of Progyny shares are held by company insiders. Comparatively, 89.5% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has stronger earnings and valuation, PGNY or SBC?

Progyny has higher revenue and earnings than SBC Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.17B	1.69	$54.34M	$0.57	40.32
SBC Medical Group	$197.94M	2.67	$46.61M	N/A	N/A

Do analysts rate PGNY or SBC?

Progyny currently has a consensus price target of $24.09, suggesting a potential upside of 4.81%. Given Progyny's stronger consensus rating and higher probable upside, equities analysts clearly believe Progyny is more favorable than SBC Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
SBC Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is PGNY or SBC more profitable?

Progyny has a net margin of 4.33% compared to SBC Medical Group's net margin of 0.00%. SBC Medical Group's return on equity of 26.72% beat Progyny's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Progyny	4.33%	10.90%	7.20%
SBC Medical Group	N/A	26.72%	19.60%

Summary

Progyny beats SBC Medical Group on 11 of the 15 factors compared between the two stocks.